Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
Clinical trial NCT05207865 · COMPLETED
Trial details
- NCT number
- NCT05207865
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2024-07-02
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.